12/17
07:32 am
aytu
Attention Deficit Hyperactivity Disorder Market to hit USD 24.6 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]
Low
Report
Attention Deficit Hyperactivity Disorder Market to hit USD 24.6 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]
12/9
08:35 am
aytu
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer [Yahoo! Finance]
12/4
12:19 am
aytu
Aytu BioPharma Disclosure Notification [Yahoo! Finance]
Low
Report
Aytu BioPharma Disclosure Notification [Yahoo! Finance]
12/3
11:45 pm
aytu
Aytu BioPharma Disclosure Notification
Low
Report
Aytu BioPharma Disclosure Notification
11/22
09:14 am
aytu
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) [Yahoo! Finance]
Medium
Report
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) [Yahoo! Finance]
11/22
09:00 am
aytu
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)
Medium
Report
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)
11/14
02:31 am
aytu
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ... [Yahoo! Finance]
High
Report
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ... [Yahoo! Finance]
11/13
07:28 pm
aytu
Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript [Seeking Alpha]
11/13
04:22 pm
aytu
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results [Yahoo! Finance]
High
Report
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results [Yahoo! Finance]
11/13
04:05 pm
aytu
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
High
Report
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
11/6
05:28 pm
aytu
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024 [Yahoo! Finance]
Medium
Report
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024 [Yahoo! Finance]
11/6
05:20 pm
aytu
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
Medium
Report
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
10/14
04:15 pm
aytu
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
Low
Report
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
10/1
08:01 am
aytu
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
Medium
Report
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
9/28
09:19 am
aytu
Aytu BioPharma Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
Low
Report
Aytu BioPharma Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
9/26
04:15 pm
aytu
Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results
High
Report
Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results